Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction

The incidence and impact of de novo fungal airway colonization and infection in lung transplant recipients (LTRs) with known chronic lung allograft dysfunction (CLAD) has not been established. We aimed to determine the 1‐year cumulative incidence and risk factors of de novo fungal colonization or infection in LTRs with CLAD and assess the impact of colonization or infection on post‐CLAD survival.

[1]  C. Kennedy,et al.  The Impact of Antifungal Prophylaxis in Lung Transplant Recipients. , 2020, Annals of the American Thoracic Society.

[2]  P. Erwin,et al.  Antifungal prophylaxis in lung transplant recipients: A systematic review and meta‐analysis , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  J. Belperio,et al.  Fungal Prophylaxis and Chronic Lung Allograft Dysfunction. , 2020, The Journal of Heart and Lung Transplantation.

[4]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  J. Perfect,et al.  Invasive Fungal Infection after Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  A. Gregson.  Infectious Triggers of Chronic Lung Allograft Dysfunction , 2016, Current Infectious Disease Reports.

[8]  J. Riera,et al.  10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  S. Keshavjee,et al.  The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant , 2015, Transplantation.

[10]  W. Kremers,et al.  Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis , 2015, Clinical transplantation.

[11]  N. Lloberas,et al.  Pre-Transplant Donor-Specific T-Cell Alloreactivity Is Strongly Associated with Early Acute Cellular Rejection in Kidney Transplant Recipients Not Receiving T-Cell Depleting Induction Therapy , 2015, PloS one.

[12]  S. Keshavjee,et al.  Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  A. Glanville.  CLAD: Does the Emperor Have New Clothes? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  G. Verleden,et al.  A new classification system for chronic lung allograft dysfunction. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  M. Netea,et al.  Corticosteroids Block Autophagy Protein Recruitment in Aspergillus fumigatus Phagosomes via Targeting Dectin-1/Syk Kinase Signaling , 2013, The Journal of Immunology.

[16]  G. Snell,et al.  Preemptive treatment with voriconazole in lung transplant recipients , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[17]  G. Opelz,et al.  The collaborative transplant study registry. , 2013, Transplantation reviews.

[18]  R. Elashoff,et al.  Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two‐Center Validation Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  S. Keshavjee,et al.  Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  M. Hannan,et al.  A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients , 2011, The Journal of Heart and Lung Transplantation.

[21]  R. Elashoff,et al.  Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  V. Valentine,et al.  Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  J. Latgé,et al.  Interaction of Aspergillus fumigatus with the alveolar macrophage. , 2006, Medical mycology.

[24]  M. Kamberi,et al.  Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia. , 2003, The Journal of infectious diseases.

[25]  N. Smedira,et al.  The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[26]  A. Mehta,et al.  Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.